The Food and Drug Administration says it is “rapidly” workingtoward issuing an emergency use authorization for the Modernavaccine — the second Covid-19 vaccine for the US market — afterits vaccine advisers voted to recommend it.
by Brian Rogers
The Food and Drug Administration says it is “rapidly” workingtoward issuing an emergency use authorization for the Modernavaccine — the second Covid-19 vaccine for the US market — afterits vaccine advisers voted to recommend it.